出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2021年11月
体外式膜型人工肺市場: 製品、コンポーネント、患者タイプ（新生児、小児科、成人）、モダリティの見通し（静脈-静脈、静脈-動脈、動脈-静脈）、用途、地域別 – 2026年までの世界予測
Extracorporeal Membrane Oxygenation Machine Market by Product, Component, Patient Type (Neonates, Pediatrics and Adults), Modality Outlook (Veno-Venous, Veno-Arterio and Arterio-Venous), Applications, and Region – Global Forecast to 2026
| ページ数 | 169 |
| 図表数 | 209 |
| 種別 | 英文調査報告書 |
| 価格 |
The global ECMO machine market is expected to reach USD 673 million by 2026 from an estimated USD 531 million in 2021, at a CAGR of 4.9% from 2021 to 2026. An ECMO machine acts as an artificial heart and lung for a patient whose own heart or lungs cannot provide enough blood flow or get enough oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of the ECMO is to let the heat and lungs recover while the patient is supported by the ECMO machine. The major factors driving the growth of this market include the increasing geriatric population and growth in disease incidence as well as favorable government regulations, investments, and initiatives. The advantages of ECMO machines have played a key part in their adoption; their speed and accuracy, as well as quick processing times. This has pushed companies to focus on product development and innovation. However, these systems are priced at a premium, which slows their greater adoption. Other factors such as declining reimbursements, lack of infrastructure, particularly in developing and underdeveloped countries, and potential risks associated with radiation exposure are also expected to hinder the growth of this market.
“Respiratory segment accounted for the largest share of global ECMO machine market in 2020”
On the basis of applications, the ECMO machine market is segmented into respiratory, cardiac and ECPR applications. The respiratory segment is expected to dominate this market during the forecast period. Growth in this market can be attributed to the increasing prevalence of target diseases, high demand for early diagnosis and diagnostic imaging, and technological advancements in the ECMO machine market. Moreover, the rising prevalence of lung diseases like tuberculosis, thoracic malignancies, osteoporosis, fractures, and CVDs increases the demand for medical imaging for diagnosis.
“Arterio-Venous segment accounted for the largest market share of the ECMO machine market in 2020”
On the basis of modality, the ECMO machine market is segmented into veno-arterio, veno-venous and arterio-venous. The arterio-venous segment accounted for the larger market share. The advantages associated with this segment, such as effective dynamic range, better medical evaluation, are contributing to the growth of this technology segment.
“Increasing number of disorders/diseases in growing population resulting in an increase in the purchase of ECMO machines ”
On the basis of patient type, the ECMO machine market is segmented into neonates, pediatric and adults. The adult segment contributed to the largest share of global ECMO machine market in 2020. ECMO has been used for more than 40 years, and its benefits with neonates with respiratory distress are well recognized. The benefits of ECMO in adult patients with cardiac or respiratory failure are still debated, as ECMO was initially associated with low survival rates. However, recent technological advancements in ECMO circuits have led to a reduction in the rate of technical issues and complications.
“Controllers, by component, have contributed the largest share in the ECMO machine market”
Based on component, the global ECMO machine market is segmented into pumps, oxygenators, controllers, cannula and accessories. The controllers segment is expected to dominate the market during the forecast period. The large share of this segment can be attributed to the greater adoption of the systems among end users due to their lowercost compared to others.
“Portable Segment, by product type, has commanded the highest growth rate in the forecast period”
Based on product type, the ECMO machine market is segmented into Static ECMO machines and Portable ECMO machines. Portable ECMO machine segment is expected to dominate the market during the forecast period. Portable ECMO machines can be transported to any desired location and they re light in weight. These systems are especially used in a variety of imaging-set ups, including intensive care units, cardiac care units, neonatal intensive care units, operating rooms, emergency rooms, and at the patient’s beside for critically ill patients or patients with mobility challenges.
“The APAC market, by region, to register highest growth rate in the forecast period”
The ECMO Machine market is segmented into five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The asia-pacific market is expected to register the highest growth in the forecast period. Growth in the ECMO machine market in the Asia Pacific is mainly driven by the growing geriatric population, particularly in Japan; increasing disposable incomes, allowing for greater affordability for advanced technologies; the rising prevalence of target diseases; and favorable government initiatives. Such factors help to drive the market for digital imaging systems in this region and draw foreign investments and partnerships. On the other hand, low hospital budgets, high equipment costs, and a lack of government investments in some countries are limiting the growth of the market in the Asia Pacific to a certain extent.
A breakdown of the primary participants referred to for this report is provided below:
•By Company Type: Tier 1–25%, Tier 2–37%, and Tier 3– 38%
•By Designation: C-level–34%, Director-level–35%, and Others–31%
•By Region: North America–24%, Europe–32%, Asia Pacific–28%, Latin America–10%, and the Middle East & Africa–6%
The ECMO machine market is dominated by Fresenius Medical care AG & Co. KGaA(Germany), Getinge Group (Sweden), Microport (China). Other leading market players include Medtronic pls (US), Terumo cardiovascular Systems Corporation (Japan), Nipro Corporation (Japan), and Livanova plc (UK).
Research Coverage
This report studies the ECMO machine market based on patient type, application, product, compnent, modality outlook and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the ECMO machine market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the ECMO machine market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the ECMO machine market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
目次
1INTRODUCTION25
1.1OBJECTIVES OF THE STUDY25
1.2MARKET DEFINITION25
1.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY26
1.3MARKETS SCOPE26
1.3.1MARKETS COVERED26
FIGURE 1ECMO MARKET SEGMENTATION26
1.3.2YEARS CONSIDERED FOR THE STUDY27
1.4CURRENCY USED FOR THE STUDY27
1.5KEY MARKET STAKEHOLDERS27
1.6SUMMARY OF CHANGES28
2RESEARCH METHODOLOGY29
2.1RESEARCH DATA29
FIGURE 2RESEARCH DESIGN29
2.1.1SECONDARY DATA SOURCES30
2.1.1.1Indicative list of secondary sources31
2.1.2PRIMARY DATA32
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION AND REGION33
2.2MARKET SIZE ESTIMATION METHODOLOGY33
FIGURE 4SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS34
2.3MARKET DATA VALIDATION AND TRIANGULATION35
FIGURE 5DATA TRIANGULATION METHODOLOGY35
2.4KEY RESEARCH ASSUMPTIONS36
2.5LIMITATIONS36
2.5.1METHODOLOGY-RELATED LIMITATIONS36
2.6RISK ASSESSMENT37
TABLE 1RISK ASSESSMENT: ECMO MARKET37
2.7GROWTH RATE ASSUMPTIONS37
2.8COVID-19 HEALTH ASSESSMENT37
2.9COVID-19 ECONOMIC ASSESSMENT37
2.10ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO38
FIGURE 6CRITERIA IMPACTING THE GLOBAL ECONOMY38
FIGURE 7RECOVERY SCENARIO OF THE GLOBAL ECONOMY (2021–2022)39
3EXECUTIVE SUMMARY40
FIGURE 8ECMO MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)40
FIGURE 9ECMO MARKET SHARE, BY MODALITY, 2021 VS. 202640
FIGURE 10ECMO MARKET, BY COMPONENT, 2021 VS. 2026 (USD MILLION)41
FIGURE 11GEOGRAPHICAL SNAPSHOT OF THE ECMO MARKET42
4PREMIUM INSIGHTS43
4.1ECMO MARKET OVERVIEW43
FIGURE 12RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH43
4.2ECMO MARKET SHARE, BY REGION AND PATIENT TYPE (2020)44
FIGURE 13NORTH AMERICA DOMINATED THE ECMO MARKET IN 202044
4.3ECMO MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)44
FIGURE 14ECMO MACHINES SEGMENT WILL CONTINUE TO DOMINATE
THE ECMO MARKET DURING THE FORECAST PERIOD44
4.4ECMO MARKET: GEOGRAPHIC SNAPSHOT45
FIGURE 15EMERGING MARKETS ARE ESTIMATED TO REGISTER HIGHER GROWTH RATES THAN DEVELOPED MARKETS45
5MARKET OVERVIEW46
5.1INTRODUCTION46
5.2MARKET DYNAMICS46
FIGURE 16ECMO MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES46
5.2.1DRIVERS47
5.2.1.1Increasing prevalence of cardiovascular and respiratory diseases47
TABLE 2NUMBER OF DEATHS FROM CARDIOVASCULAR AND RESPIRATORY DISEASES ACROSS THE GLOBE, 1990 VS. 201947
5.2.1.2Growing adoption of ECMO in lung transplantation procedures47
5.2.1.3Growth in the number of ECMO centers48
TABLE 3GLOBAL INCREASE IN THE NUMBER OF ECMO CENTERS48
5.2.1.4Technological advancements in ECMO machines48
5.2.2RESTRAINTS49
5.2.2.1Complications associated with ECMO49
5.2.2.2High cost of ECMO procedures49
TABLE 4AVERAGE COST OF ECMO IN VARIOUS COUNTRIES49
5.2.3OPPORTUNITIES50
5.2.3.1Increasing survival rates with ECMO50
5.2.4CHALLENGES50
5.2.4.1Shortage of skilled professionals50
5.2.4.2Eligibility issues for ECMO50
5.2.4.3Issues related to selecting the right equipment50
5.2.4.4Risks related to the transport of ECMO patients51
5.2.4.5Issues related to treatment decision-making51
5.3REGULATORY LANDSCAPE51
TABLE 5INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING
THE ECMO MARKET51
5.3.1NORTH AMERICA52
5.3.1.1US52
TABLE 6CLASSIFICATION OF MEDICAL DEVICES BY US FDA52
5.3.1.2Canada53
5.3.2EUROPE53
5.3.3ASIA PACIFIC53
5.3.3.1India53
5.3.3.2Japan53
TABLE 7CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY IN JAPAN54
5.3.3.3China54
TABLE 8NMPA MEDICAL DEVICE CLASSIFICATION55
5.4COVID-19 IMPACT ON THE ECMO MARKET55
5.4.1REIMBURSEMENT SCENARIO55
5.5PATENT ANALYSIS56
5.5.1PATENTS GRANTED FOR ECMO MACHINES56
TABLE 9PATENTS GRANTED FROM 2016 TO 202157
5.5.2PUBLICATION TRENDS FOR PATENTS ON ECMO MACHINES57
TABLE 10FILED PATENTS, 2000–202157
TABLE 11GRANTED PATENTS, 2010–202158
TABLE 12PUBLISHED PATENTS, 2016–202158
5.6VALUE CHAIN ANALYSIS58
FIGURE 17VALUE CHAIN OF THE ECMO MARKET59
5.7PRICING TREND ANALYSIS59
TABLE 13AVERAGE PRICE OF ECMO, BY COUNTRY, 2020 (USD)59
5.8PORTER’S FIVE FORCES ANALYSIS60
TABLE 14ECMO MARKET: PORTER’S FIVE FORCES ANALYSIS60
5.8.1THREAT OF NEW ENTRANTS60
FIGURE 18THREAT OF NEW ENTRANTS60
5.8.2THREAT OF SUBSTITUTES61
FIGURE 19THREAT OF SUBSTITUTES61
5.8.3BARGAINING POWER OF SUPPLIERS61
FIGURE 20BARGAINING POWER OF SUPPLIERS62
5.8.4BARGAINING POWER OF BUYERS62
FIGURE 21BARGAINING POWER OF BUYERS62
5.8.5INTENSITY OF COMPETITIVE RIVALRY63
FIGURE 22INTENSITY OF COMPETITIVE RIVALRY63
5.9ECOSYSTEM LANDSCAPE63
FIGURE 23ECMO MARKET: ECOSYSTEM LANDSCAPE64
6EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY PRODUCT65
6.1INTRODUCTION66
TABLE 15ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)66
6.2ECMO MACHINES66
6.2.1STATIC ECMO MACHINES SEGMENT TO DOMINATE
THE ECMO MACHINES MARKET66
TABLE 16ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)66
TABLE 17ECMO MACHINES MARKET, BY REGION, 2018–2026 (USD MILLION)67
TABLE 18ECMO MACHINES MARKET, BY COMPONENT, 2018–2026 (USD MILLION)67
TABLE 19ECMO MACHINES MARKET, BY MODALITY, 2018–2026 (USD MILLION)67
TABLE 20ECMO MACHINES MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)68
TABLE 21ECMO MACHINES MARKET, BY APPLICATION, 2018–2026 (USD MILLION)68
6.2.2PORTABLE ECMO MACHINES68
TABLE 22PORTABLE ECMO MACHINES MARKET, BY REGION,
2018–2026 (USD MILLION)68
TABLE 23PORTABLE ECMO MACHINES MARKET, BY COMPONENT,
2018–2026 (USD MILLION)69
TABLE 24PORTABLE ECMO MACHINES MARKET, BY MODALITY,
2018–2026 (USD MILLION)69
TABLE 25PORTABLE ECMO MACHINES MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION)69
TABLE 26PORTABLE ECMO MACHINES MARKET, BY APPLICATION,
2018–2026 (USD MILLION)70
6.2.3STATIC ECMO MACHINES70
TABLE 27STATIC ECMO MACHINES MARKET, BY REGION, 2018–2026 (USD MILLION)70
TABLE 28STATIC ECMO MACHINES MARKET, BY COMPONENT,
2018–2026 (USD MILLION)70
TABLE 29STATIC ECMO MACHINES MARKET, BY MODALITY,
2018–2026 (USD MILLION)71
TABLE 30STATIC ECMO MACHINES MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION)71
TABLE 31STATIC ECMO MACHINES MARKET, BY APPLICATION,
2018–2026 (USD MILLION)71
6.3SOFTWARE72
6.3.1SOFTWARE SEGMENT TO GROW AT A STEADY CAGR DURING
THE FORECAST PERIOD72
TABLE 32ECMO SOFTWARE MARKET, BY REGION, 2018–2026 (USD MILLION)72
TABLE 33ECMO SOFTWARE MARKET, BY MODALITY, 2018–2026 (USD MILLION)72
TABLE 34ECMO SOFTWARE MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)72
TABLE 35ECMO SOFTWARE MARKET, BY APPLICATION, 2018–2026 (USD MILLION)73
7EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY COMPONENT74
7.1INTRODUCTION75
TABLE 36ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)75
7.2PUMPS75
7.2.1CENTRIFUGAL BLOOD PUMPS HAVE BECOME THE PUMP OF CHOICE FOR ADULT EXTRACORPOREAL LIFE SUPPORT75
TABLE 37ECMO MARKET FOR PUMPS, BY REGION, 2018–2026 (USD MILLION)75
7.3OXYGENATORS76
7.3.1PMP OXYGENATORS HAVE SIGNIFICANTLY LESS PRIMING VOLUME76
TABLE 38ECMO MARKET FOR OXYGENATORS, BY REGION, 2018–2026 (USD MILLION)76
7.4CONTROLLERS76
7.4.1CONTROLLERS ALLOW OPERATORS OF ECMO CIRCUITS TO ADJUST THE SETTINGS AS NEEDED76
TABLE 39ECMO MARKET FOR CONTROLLERS, BY REGION, 2018–2026 (USD MILLION)77
7.5CANNULAS77
7.5.1THE CHOICE OF CANNULAS IS IMPORTANT IN ECMO PROCEDURES77
TABLE 40ECMO MARKET FOR CANNULAS, BY REGION, 2018–2026 (USD MILLION)77
7.6ACCESSORIES78
TABLE 41ECMO MARKET FOR ACCESSORIES, BY REGION, 2018–2026 (USD MILLION)78
8EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY MODALITY79
8.1INTRODUCTION80
TABLE 42ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)80
8.2VENOARTERIAL ECMO80
8.2.1INCREASING INCIDENCE OF HEART-LUNG FAILURE TO DRIVE
THE GROWTH OF THIS MARKET SEGMENT80
TABLE 43VENOARTERIAL ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)81
8.3VENOVENOUS ECMO81
8.3.1VENOVENOUS ECMO IS USED WHEN ADEQUATE
HEART FUNCTION IS AVAILABLE81
TABLE 44VENOVENOUS ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)81
8.4ARTERIOVENOUS ECMO82
8.4.1ARTERIOVENOUS ECMO MACHINES ARE SMALLER AND MORE PORTABLE82
TABLE 45ARTERIOVENOUS ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)82
9EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY PATIENT TYPE83
9.1INTRODUCTION84
TABLE 46COMMON INDICATIONS FOR ECMO IN NEONATES, PEDIATRIC
PATIENTS, AND ADULTS84
TABLE 47ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)84
9.2NEONATES85
9.2.1A LARGE NUMBER OF NEONATES ARE CARED FOR WITH ECMO WORLDWIDE85
TABLE 48ECMO MARKET FOR NEONATES, BY REGION, 2018–2026 (USD MILLION)85
9.3PEDIATRIC PATIENTS86
9.3.1PEDIATRIC PATIENTS FORM A LARGE PATIENT GROUP FOR ECMO PROCEDURES86
TABLE 49ECMO MARKET FOR PEDIATRIC PATIENTS, BY REGION,
2018–2026 (USD MILLION)86
9.4ADULTS86
9.4.1TECHNOLOGICAL ADVANCEMENTS ARE DRIVING THE USE
OF ECMO IN ADULT PATIENTS86
TABLE 50ECMO MARKET FOR ADULTS, BY REGION, 2018–2026 (USD MILLION)87
10EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION88
10.1INTRODUCTION89
TABLE 51ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)89
10.2RESPIRATORY APPLICATIONS89
TABLE 52ECMO MARKET FOR RESPIRATORY APPLICATIONS, BY REGION,
2018–2026 (USD MILLION)89
10.2.1RESPIRATORY APPLICATIONS FOR NEONATES90
TABLE 53NUMBER OF NEONATES RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS90
10.2.2RESPIRATORY APPLICATIONS FOR PEDIATRIC PATIENTS90
TABLE 54NUMBER OF PEDIATRIC PATIENTS RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS90
10.2.3RESPIRATORY APPLICATIONS FOR ADULTS90
TABLE 55NUMBER OF ADULTS RECEIVING ECMO SUPPORT
FOR RESPIRATORY APPLICATIONS90
10.3CARDIAC APPLICATIONS91
TABLE 56ECMO MARKET FOR CARDIAC APPLICATIONS, BY REGION,
2018–2026 (USD MILLION)91
10.3.1CARDIAC APPLICATIONS FOR ADULTS91
10.3.2CARDIAC APPLICATIONS FOR PEDIATRIC PATIENTS91
10.3.3CARDIAC APPLICATIONS FOR NEONATES91
10.4EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)92
TABLE 57ECMO MARKET FOR ECPR APPLICATIONS, BY REGION,
2018–2026 (USD MILLION)92
10.4.1ECPR APPLICATIONS FOR ADULTS92
10.4.2ECPR APPLICATIONS FOR PEDIATRIC PATIENTS92
10.4.3ECPR APPLICATIONS FOR NEONATES93
11EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY REGION94
11.1INTRODUCTION95
TABLE 58ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)95
11.2NORTH AMERICA95
FIGURE 24NORTH AMERICA: ECMO MARKET SNAPSHOT96
TABLE 59NORTH AMERICA: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)96
TABLE 60NORTH AMERICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)97
TABLE 61NORTH AMERICA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)97
TABLE 62NORTH AMERICA: ECMO MARKET, BY COMPONENT,
2018–2026 (USD MILLION)97
TABLE 63NORTH AMERICA: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)98
TABLE 64NORTH AMERICA: ECMO MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION)98
TABLE 65NORTH AMERICA: ECMO MARKET, BY APPLICATION,
2018–2026 (USD MILLION)98
11.2.1US99
11.2.1.1US accounted for the largest share of the North American market99
TABLE 66US: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)99
TABLE 67US: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)99
11.2.2CANADA100
11.2.2.1Implementation of the ABF model in Canadian hospitals to drive market growth100
TABLE 68CANADA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)100
TABLE 69CANADA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)100
11.3EUROPE101
TABLE 70EUROPE: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)101
TABLE 71EUROPE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)101
TABLE 72EUROPE: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)101
TABLE 73EUROPE: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)102
TABLE 74EUROPE: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)102
TABLE 75EUROPE: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)102
TABLE 76EUROPE: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)103
11.3.1GERMANY103
11.3.1.1Increasing volume of ECMO procedures to drive market
growth in Germany103
TABLE 77GERMANY: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)103
TABLE 78GERMANY: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)103
11.3.2FRANCE104
11.3.2.1Rising healthcare spending to drive market growth in France104
TABLE 79FRANCE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)104
TABLE 80FRANCE: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)104
11.3.3UK104
11.3.3.1Rising adoption of ECMO procedures and increasing prevalence of lifestyle diseases to drive market growth in the UK104
TABLE 81UK: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)105
TABLE 82UK: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)105
11.3.4ITALY105
11.3.4.1High burden of CVDs contributing to the growth of the ECMO market in Italy105
TABLE 83ITALY: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)106
TABLE 84ITALY: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)106
11.3.5SPAIN106
11.3.5.1High adoption of advanced technologies to drive market
growth in Spain106
TABLE 85SPAIN: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)107
TABLE 86SPAIN: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)107
11.4REST OF EUROPE107
TABLE 87REST OF EUROPE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)107
TABLE 88REST OF EUROPE: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)108
11.5ASIA PACIFIC108
FIGURE 25ASIA PACIFIC: ECMO MARKET SNAPSHOT108
TABLE 89ASIA PACIFIC: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)109
TABLE 90ASIA PACIFIC: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)109
TABLE 91ASIA PACIFIC: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)109
TABLE 92ASIA PACIFIC: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)110
TABLE 93ASIA PACIFIC: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)110
TABLE 94ASIA PACIFIC: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)110
TABLE 95ASIA PACIFIC: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)111
11.5.1JAPAN111
11.5.1.1Favorable healthcare infrastructure in Japan to drive market growth111
TABLE 96JAPAN: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)111
TABLE 97JAPAN: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)112
11.5.2CHINA112
11.5.2.1Rising geriatric population and increasing prevalence of
CVD to drive market growth in China112
TABLE 98CHINA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)113
TABLE 99CHINA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)113
11.5.3INDIA113
11.5.3.1Growing applications and rising adoption of ECMO to drive market growth in India113
TABLE 100INDIA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)113
TABLE 101INDIA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)114
11.5.4AUSTRALIA114
11.5.4.1Technological advancements to drive market growth in Australia114
TABLE 102AUSTRALIA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)114
TABLE 103AUSTRALIA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)114
11.5.5SOUTH KOREA115
11.5.5.1Increasing incidence of cardiac disorders to drive market growth in South Korea115
TABLE 104SOUTH KOREA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)115
TABLE 105SOUTH KOREA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)115
11.5.6REST OF APAC115
TABLE 106REST OF APAC: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)116
TABLE 107REST OF APAC: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)116
11.6LATIN AMERICA116
TABLE 108LATIN AMERICA: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)116
TABLE 109LATIN AMERICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)117
TABLE 110LATIN AMERICA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)117
TABLE 111LATIN AMERICA: ECMO MARKET, BY COMPONENT,
2018–2026 (USD MILLION)117
TABLE 112LATIN AMERICA: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)118
TABLE 113LATIN AMERICA: ECMO MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION)118
TABLE 114LATIN AMERICA: ECMO MARKET, BY APPLICATION,
2018–2026 (USD MILLION)118
11.6.1BRAZIL119
11.6.1.1Rising adoption of ECMO as a bridge to heart and lung transplantation to drive market growth in Brazil119
TABLE 115BRAZIL: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)119
TABLE 116BRAZIL: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)119
11.6.2MEXICO120
11.6.2.1High burden of CVDs in the country to drive market growth in Mexico120
TABLE 117MEXICO: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)120
TABLE 118MEXICO: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)120
11.6.3REST OF LATIN AMERICA121
TABLE 119REST OF LATIN AMERICA: ECMO MARKET, BY PRODUCT,
2018–2026 (USD MILLION)121
TABLE 120REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)121
11.6.4MIDDLE EAST & AFRICA121
11.6.4.1Increasing prevalence of target diseases to drive market growth in the Middle East & Africa121
TABLE 121MIDDLE EAST & AFRICA: ECMO MARKET, BY PRODUCT,
2018–2026 (USD MILLION)122
TABLE 122MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION)122
TABLE 123MIDDLE EAST & AFRICA: ECMO MARKET, BY COMPONENT,
2018–2026 (USD MILLION)122
TABLE 124MIDDLE EAST & AFRICA: ECMO MARKET, BY MODALITY,
2018–2026 (USD MILLION)123
TABLE 125MIDDLE EAST & AFRICA: ECMO MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION)123
TABLE 126MIDDLE EAST & AFRICA: ECMO MARKET, BY APPLICATION,
2018–2026 (USD MILLION)123
12COMPETITIVE LANDSCAPE124
12.1INTRODUCTION124
FIGURE 26KEY DEVELOPMENTS BY LEADING PLAYERS IN THE ECMO MARKET,
2018–2021124
12.2REVENUE SHARE ANALYSIS125
FIGURE 27REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET125
12.3MARKET SHARE ANALYSIS126
FIGURE 28ECMO MARKET SHARE, BY KEY PLAYER, 2020126
TABLE 127ECMO MARKET: DEGREE OF COMPETITION126
12.4COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020)127
12.4.1TERMINOLOGY/NOMENCLATURE127
12.4.1.1Stars127
12.4.1.2Emerging leaders127
12.4.1.3Pervasive players128
12.4.1.4Participants128
FIGURE 29ECMO MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020128
12.5COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (2020)129
12.5.1PROGRESSIVE COMPANIES129
12.5.2RESPONSIVE COMPANIES129
12.5.3DYNAMIC COMPANIES129
12.5.4STARTING BLOCKS129
FIGURE 30ECMO MARKET: COMPETITIVE LEADERSHIP MAPPING FOR
SMES/START-UPS, 2020130
12.6COMPETITIVE BENCHMARKING131
TABLE 128PRODUCT FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET131
TABLE 129APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS
IN THE ECMO MARKET132
TABLE 130COMPANY FOOTPRINT ANALYSIS IN THE ECMO MARKET133
12.7COMPETITIVE SCENARIO (2018–2021)134
12.7.1NEW PRODUCT LAUNCHES & APPROVALS134
13COMPANY PROFILES135
13.1KEY PLAYERS135
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1FRESENIUS MEDICAL CARE AG & CO. KGAA135
TABLE 131FRESENIUS MEDICAL CARE AG & CO. KGAA: BUSINESS OVERVIEW135
FIGURE 31FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT136
TABLE 132FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT OFFERINGS136
TABLE 133FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT LAUNCHES137
13.1.2GETINGE GROUP138
TABLE 134GETINGE GROUP: BUSINESS OVERVIEW138
FIGURE 32GETINGE GROUP: COMPANY SNAPSHOT139
TABLE 135GETINGE GROUP: PRODUCT OFFERINGS140
13.1.3MEDTRONIC PLC141
TABLE 136MEDTRONIC PLC: BUSINESS OVERVIEW141
FIGURE 33MEDTRONIC PLC: COMPANY SNAPSHOT142
TABLE 137MEDTRONIC PLC: PRODUCT OFFERINGS142
13.1.4MICROPORT144
TABLE 138MICROPORT: BUSINESS OVERVIEW144
FIGURE 34MICROPORT: COMPANY SNAPSHOT145
TABLE 139MICROPORT: PRODUCT OFFERINGS145
13.1.5TERUMO CARDIOVASCULAR SYSTEMS CORPORATION146
FIGURE 35TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: COMPANY SNAPSHOT146
TABLE 140TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: BUSINESS OVERVIEW147
TABLE 141TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: PRODUCT OFFERINGS147
13.1.6NIPRO CORPORATION148
TABLE 142NIPRO CORPORATION: BUSINESS OVERVIEW148
FIGURE 36NIPRO CORPORATION: COMPANY SNAPSHOT149
TABLE 143NIPRO CORPORATION: PRODUCT OFFERINGS149
13.1.7LIVANOVA PLC150
TABLE 144LIVANOVA PLC.: BUSINESS OVERVIEW150
FIGURE 37LIVANOVA PLC.: COMPANY SNAPSHOT151
TABLE 145LIVANOVA PLC: PRODUCT OFFERINGS151
13.1.8EUROSETS S.R.L.152
TABLE 146EUROSETS S.R.L.: BUSINESS OVERVIEW152
TABLE 147EUROSETS S.R.L.: PRODUCT OFFERINGS152
13.1.9ORIGEN BIOMEDICAL, INC.153
TABLE 148ORIGEN BIOMEDICAL, INC.: BUSINESS OVERVIEW153
TABLE 149ORIGEN BIOMEDICAL, INC.: PRODUCT OFFERINGS153
13.1.10CYTOSORBENTS CORPORATION154
TABLE 150CYTOSORBENTS CORPORATION: BUSINESS OVERVIEW154
TABLE 151CYTOSORBENTS CORPORATION: PRODUCT OFFERINGS154
13.1.11ABIOMED155
TABLE 152ABIOMED: BUSINESS OVERVIEW155
TABLE 153ABIOMED: PRODUCT OFFERINGS155
13.1.12BRAILE BIOMÉDICA156
TABLE 154BRAILE BIOMÉDICA: BUSINESS OVERVIEW156
TABLE 155BRAILE BIOMÉDICA: PRODUCT OFFERINGS156
13.1.13SPECTRUM MEDICAL157
TABLE 156SPECTRUM MEDICAL: BUSINESS OVERVIEW157
TABLE 157SPECTRUM MEDICAL: PRODUCT OFFERINGS157
13.1.14HAEMONETICS158
TABLE 158HAEMONETICS: BUSINESS OVERVIEW158
TABLE 159HAEMONETICS: PRODUCT OFFERINGS158
13.1.15XENIOS AG159
TABLE 160XENIOS AG: BUSINESS OVERVIEW159
TABLE 161XENIOS AG: PRODUCT OFFERINGS159
TABLE 162XENIOS AG: PRODUCT LAUNCHES160
13.1.16KANEKA CORPORATION161
TABLE 163KANEKA CORPORATION: BUSINESS OVERVIEW161
TABLE 164KANEKA CORPORATION: PRODUCT OFFERINGS161
13.1.17SB-KAWASUMI LABORATORIES, INC.162
TABLE 165SB-KAWASUMI LABORATORIES, INC.: BUSINESS OVERVIEW162
TABLE 166SB-KAWASUMI LABORATORIES, INC.: PRODUCT OFFERINGS162
13.1.18WEIGAO GROUP163
TABLE 167WEIGAO GROUP: BUSINESS OVERVIEW163
TABLE 168WEIGAO GROUP: PRODUCT OFFERINGS163
13.1.19ZHENGYUAN TECHNOLOGY164
TABLE 169ZHENGYUAN TECHNOLOGY: BUSINESS OVERVIEW164
TABLE 170ZHENGYUAN TECHNOLOGY: PRODUCT OFFERINGS164
13.1.20BREETHE, INC.165
TABLE 171BREETHE, INC.: BUSINESS OVERVIEW165
TABLE 172BREETHE, INC.: PRODUCT OFFERINGS165
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14APPENDIX166
14.1DISCUSSION GUIDE166
14.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL170
14.3AVAILABLE CUSTOMIZATIONS172
14.4RELATED REPORTS172
14.5AUTHOR DETAILS174
お問合せフォーム